Is Philip Morris Stock Overvalued?
If there is one industry that can be termed truly…
Buy
65
NTNX Quote, Financials, Valuation and Earnings
Last price:
$66.20
Seasonality move
:
-9.18%
Day range:
$63.97 - $66.20
52-week range:
$43.35 - $75.80
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
8.06x
P/B ratio:
--
Volume:
1.7M
Avg. volume:
2.4M
1-year change:
19.22%
Market cap:
$17.5B
Revenue:
$2.1B
EPS (TTM):
-$0.35
Analysts' Opinion
-
Consensus RatingNutanix has received a consensus rating of Buy. The company's average rating is a Buy based on 6 Buy ratings, 3 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $81.89, Nutanix has an estimated upside of 25.14% from its current price of $65.44.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $73.11 representing 100% downside risk from its current price of $65.44.
Fair Value
-
According to the consensus of 9 analysts, Nutanix has 25.14% upside to fair value with a price target of $81.89 per share.
NTNX vs. S&P 500
-
Over the past 5 trading days, Nutanix has overperformed the S&P 500 by 2.59% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Nutanix does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Nutanix has grown year-over-year revenues for 9 quarters straight. In the most recent quarter Nutanix reported revenues of $591M.
Earnings Growth
-
Nutanix has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Nutanix reported earnings per share of $0.10.
Enterprise value:
17B
EV / Invested capital:
-148.28x
Price / LTM sales:
8.06x
EV / EBIT:
169.83x
EV / Revenue:
7.64x
PEG ratio (5yr expected):
--
EV / Free cash flow:
27.59x
Price / Operating cash flow:
29.12x
Enterprise value / EBITDA:
98.17x
Gross Profit (TTM):
$1.9B
Return On Assets:
-3.19%
Net Income Margin (TTM):
-3.55%
Return On Equity:
--
Return On Invested Capital:
-24.45%
Operating Margin:
4.61%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2023-10-31 | 2024-10-31 | |
| Income Statement | ||||||
| Revenue | $1.6B | $1.9B | $2.2B | $511.1M | $591M | |
| Gross Profit | $1.3B | $1.6B | $1.9B | $429.1M | $508.3M | |
| Operating Income | -$401.9M | -$132.2M | $40.5M | -$5.7M | $27.3M | |
| EBITDA | -$311.4M | -$11M | $173.5M | $23.6M | $55.7M | |
| Diluted EPS | -$2.14 | -$0.74 | -$0.35 | -$0.07 | $0.10 | |
| Period Ending | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.6B | $1.6B | $1.7B | $1.9B | $1.5B | |
| Total Assets | $2.3B | $2.3B | $2.4B | $2.6B | $2.2B | |
| Current Liabilities | $779.6M | $904.8M | $1.1B | $1.1B | $1.2B | |
| Total Liabilities | $2.9B | $3B | $3.1B | $3.2B | $2.9B | |
| Total Equity | -$557.4M | -$698.7M | -$791M | -$642.2M | -$685.3M | |
| Total Debt | $994.6M | $1.3B | $1.3B | $1.2B | $570.5M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2023-10-31 | 2024-10-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $126.1M | $352.4M | $689.2M | $145.5M | $161.8M | |
| Cash From Investing | -$53.6M | -$83.8M | $543.6M | -$42.2M | -$28.2M | |
| Cash From Financing | $56.7M | -$137.4M | -$1.1B | -$4.4M | -$72.2M | |
| Free Cash Flow | $66.2M | $293.6M | $617.1M | $132.5M | $151.9M | |
NTNX
Sector
Market Cap
$17.5B
$117.2M
Price % of 52-Week High
86.33%
68.86%
Dividend Yield
0%
0%
Shareholder Yield
1.58%
0.91%
1-Year Price Total Return
19.22%
-3.38%
Beta (5-Year)
1.163
0.915
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$64.16
200-day SMA
Buy
Level
$60.71
Bollinger Bands (100)
Buy
Level
59.56 - 67.88
Chaikin Money Flow
Buy
Level
10.1M
20-day SMA
Buy
Level
$63.52
Relative Strength Index (RSI14)
Buy
Level
53.79
ADX Line
Buy
Level
21.36
Williams %R
Neutral
Level
-26.2849
50-day SMA
Sell
Level
$66.47
MACD (12, 26)
Sell
Level
-0.14
25-day Aroon Oscillator
Sell
Level
-52
On Balance Volume
Neutral
Level
250.2M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.8726)
Sell
CA Score
(Annual)
Level (-3.6792)
Buy
Beneish M-Score
(Annual)
Level (-3.7566)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (6.0121)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (7)
Sell
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Nutanix Inc is engaged in cloud software, offering organizations a single platform for running applications and managing data, anywhere. Its Nutanix Cloud Platform is designed to enable organizations to build a hybrid multicloud infrastructure, providing a consistent cloud operating model with a single platform for running applications and managing data in core data centers, at the edge, and in public clouds, all while supporting a variety of hypervisors and container platforms. The company is into a single operating and reportable segment that is subscription-based business model. Key revenue is generated from United States.
Stock Forecast FAQ
In the current month, NTNX has received 6 Buy ratings 3 Hold ratings, and 0 Sell ratings. The NTNX average analyst price target in the past 3 months is $81.89.
-
Where Will Nutanix Stock Be In 1 Year?
According to analysts, the consensus estimate is that Nutanix share price will rise to $81.89 per share over the next 12 months.
-
What Do Analysts Say About Nutanix?
Analysts are divided on their view about Nutanix share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Nutanix is a Sell and believe this share price will drop from its current level to $73.11.
-
What Is Nutanix's Price Target?
The price target for Nutanix over the next 1-year time period is forecast to be $81.89 according to 9 Wall Street analysts, 6 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.
-
Is NTNX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Nutanix is a Buy. 6 of 9 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of NTNX?
You can purchase shares of Nutanix via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Nutanix shares.
-
What Is The Nutanix Share Price Today?
Nutanix was last trading at $66.20 per share. This represents the most recent stock quote for Nutanix. Yesterday, Nutanix closed at $65.44 per share.
-
How To Buy Nutanix Stock Online?
In order to purchase Nutanix stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
What Quantum Stocks Should I Buy?
The last several years have seen a series of tech…
Will Sirius XM Be a 10-Bagger Stock?
Last year, Warren Buffett surprised practically everyone when he acquired…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
32
FTAI alert for Jan 22
FTAI Aviation [FTAI] is up 9.38% over the past day.
Sell
2
EDU alert for Jan 22
New Oriental Education & Technology Group [EDU] is down 0.56% over the past day.
Buy
51
GH alert for Jan 22
Guardant Health [GH] is up 4.92% over the past day.
